The Pharmaceuticals and Medical Devices Agency (PMDA) of Japan has posted a press release titled “Press Release regarding international activities related to Pharmacopoeia.” The announcement signals PMDA’s ongoing involvement in international pharmacopoeial collaboration and standard‑setting efforts. No further details were provided in the brief notice. The full release can be accessed on the PMDA website.
Regulatorische Updates23. Aug. 2026•1 Min. Lesezeit
PMDA Issues Press Release on International Pharmacopoeia Activities
The Japan Pharmaceuticals and Medical Devices Agency announced a new press release covering its international pharmacopoeia initiatives.
Zusammengestellt vom PharmaCountry-Team · Quelle: Pharmaceuticals and Medical Devices Agency (PMDA)
Bewertungen
(0)
(0)
(0)
(0)
(0)
Weitere Artikel
Alle Einblicke anzeigenStudien & Berichte
Global Finished Dosage Manufacturing Landscape 2026
5. Okt. 2026
Regulatorische UpdatesKorea Korus hit with 1‑month manufacturing suspension over missing post‑marketing safety test
28. Sept. 2026
AnalysePharma distributors set delivery cut‑offs ahead of Chuseok holiday (Sep 21‑23)
28. Sept. 2026
Bewertung hinterlassen